Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 153 participants.
Also called NCT01049919
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 153 participants
- Sponsor
- Zimmer Biomet
- Registry
-
NCT01049919
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01049919. Randomized; double masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2016-06 (actual). Results posted on 2021-05-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
- Acronym
- MOBILE
- Condition
- Critical Limb Ischemia
- Condition
- Peripheral Arterial Disease
- Condition
- Peripheral Vascular Disease
- Intervention (Device)
- Bone marrow concentration device
- Intervention (Procedure)
- Placebo procedure (sham)
- Lead sponsor
- Zimmer Biomet
Record details
- Record id
cardio:ct-nct01049919- Content hash
f16632290bb8fca2e77289e61fcaf36223f811a6fab7969bc4df9e09cfcb9059